2769 Article Views
Publication Date: 16 Feb 2010
Journal: Breast Cancer: Basic and Clinical Research
doi: 10.4137/BCBCR.S0
Curcumin is a compound with anti-tumor effects in a tolerable dose. A recent paper by Rowe et al described that curcumin induced DNA damage in triple negative breast cancer cells and regulated BRCA1 protein expression and modification. Related research and potential use of curcumin will be discussed in this article.
Discussion
No comments yet...Be the first to comment.
It was a pleasure participating as a reviewer for Clinical Medicine Insights: Case Reports. The online access was smooth and very user-friendly. The navigation process for submission of reviewer comments was flawless.Overall, a very pleasant process. The case report that I reviewed was a very interesting one, very well written and with many interesting points for readers.Macaulay Onuigbo (Associate Professor, College of Medicine, Mayo Clinic, Rochester, MN Nephrologist/Transplant, Physician/Hypertension Specialist, Midelfort Clinic, Mayo Health System, Eau Claire, WI, Regional Direct) What Your Colleagues Say
Copyright © 2012 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)